TYSABRI® 300 MG
$3,999.00
TYSABRI is used to treat multiple sclerosis (MS). MS causes inflammation in the brain that damages the nerve cells. TYSABRI stops the cells that cause inflammation from going into your brain. This reduces nerve damage caused by MS.
- Brand: TYSABRI®
- Manufacturer: Biogen Inc.
- Active Substances: Natalizumab
- 15mL vial 20 mg/mL 1x15mL vial
Additional information
| Language | English, Non=English |
|---|
TYSABRI is a biologic medication designed for patients with relapsing forms of multiple sclerosis and moderate to severe Crohn’s disease who have not responded adequately to other treatments. It functions by binding to and inhibiting the adhesion of immune cells to blood vessel walls, thereby reducing the inflammatory processes that contribute to these conditions. Administered as an intravenous infusion every four weeks, TYSABRI provides a targeted approach to managing chronic autoimmune diseases, helping to improve patients’ quality of life.
Main Treatment Areas
- Multiple Sclerosis (MS): TYSABRI is indicated for patients with relapsing forms of MS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It helps to reduce the frequency of relapses, delay disease progression, and mitigate the development of new or enlarging lesions as seen on MRI.
- Crohn’s Disease: TYSABRI is used for patients with moderate to severe Crohn’s disease who have not responded to conventional therapies. It is effective in inducing and maintaining remission, reducing symptoms, and improving overall disease management in patients with this chronic inflammatory bowel disease.
Key Benefits
- Reduced Relapse Rates: In MS, TYSABRI has been shown to significantly decrease the frequency of relapses and slow the progression of disability, offering substantial benefits in disease management.
- Improved Quality of Life: Patients often experience fewer symptoms and improved functionality, contributing to a better overall quality of life.
- Disease Control: For Crohn’s disease, TYSABRI provides an effective option for patients who have not responded to other treatments, helping to achieve and maintain clinical remission.
Safety Information
TYSABRI can increase the risk of serious infections, including opportunistic infections like progressive multifocal leukoencephalopathy (PML). Patients must be regularly monitored for signs of PML and other infections. Common side effects include headaches, fatigue, and joint pain. Long-term use may also be associated with liver enzyme abnormalities. It is important for patients to inform their healthcare provider of any medical history or concurrent medications to assess potential interactions and risks.
TYSABRI Purchase Information
For healthcare providers and institutions seeking bulk purchases, Dr Sales Direct offers competitive wholesale pricing on TYSABRI® 300 mg. As a trusted wholesale supplier, we ensure that you receive the best value for your needs. To view specific wholesale prices and place an order, please sign in. Our pricing structure is designed to accommodate varying quantities and provide cost-effective solutions for your procurement needs. Explore our page for more details and to access exclusive wholesale rates.
